- Home
- GRI vs JWEL Comparison
GRI vs JWEL Comparison
Compare GRI & JWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRI
- JWEL
- Stock Information
- Founded
- GRI 2018
- JWEL 2012
- Country
- GRI United States
- JWEL China
- Employees
- GRI N/A
- JWEL N/A
- Industry
- GRI Biotechnology: Pharmaceutical Preparations
- JWEL Other Consumer Services
- Sector
- GRI Health Care
- JWEL Consumer Discretionary
- Exchange
- GRI Nasdaq
- JWEL Nasdaq
- Market Cap
- GRI 5.6M
- JWEL 6.0M
- IPO Year
- GRI N/A
- JWEL 2021
- Fundamental
- Price
- GRI $0.42
- JWEL $2.93
- Analyst Decision
- GRI Strong Buy
- JWEL
- Analyst Count
- GRI 2
- JWEL 0
- Target Price
- GRI $11.50
- JWEL N/A
- AVG Volume (30 Days)
- GRI 172.9K
- JWEL 14.5K
- Earning Date
- GRI 03-27-2025
- JWEL 12-19-2024
- Dividend Yield
- GRI N/A
- JWEL 6.88%
- EPS Growth
- GRI N/A
- JWEL N/A
- EPS
- GRI N/A
- JWEL N/A
- Revenue
- GRI N/A
- JWEL $160,009,293.00
- Revenue This Year
- GRI N/A
- JWEL N/A
- Revenue Next Year
- GRI N/A
- JWEL N/A
- P/E Ratio
- GRI N/A
- JWEL N/A
- Revenue Growth
- GRI N/A
- JWEL N/A
- 52 Week Low
- GRI $0.30
- JWEL $1.00
- 52 Week High
- GRI $12.31
- JWEL $3.71
- Technical
- Relative Strength Index (RSI)
- GRI 28.18
- JWEL 50.09
- Support Level
- GRI $0.43
- JWEL $2.82
- Resistance Level
- GRI $0.60
- JWEL $3.05
- Average True Range (ATR)
- GRI 0.06
- JWEL 0.16
- MACD
- GRI -0.00
- JWEL 0.00
- Stochastic Oscillator
- GRI 10.91
- JWEL 37.40
About GRI GRI Bio Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist, for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
About JWEL Jowell Global Ltd.
Jowell Global Ltd is a cosmetics, health and nutritional supplements, and household products e-commerce platform. It operates under Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing sales channels. The company's major merchandise categories are Cosmetic products, Health and nutritional supplements, and Household Products.